Codexis is a biotechnology company that engineers enzymes for pharmaceutical, fine chemicals, flavors & fragrances, agrochemicals and more. Codexis engineers custom enzymes and microorganisms, which are sometimes referred to as biocatalysts. The Company's Codexis' proprietary technology called CodeEvolver is directed evolution technology based on the concept that natural genetic mutation and selection can be accelerated in the research laboratory to obtain specific improvements in the function of single proteins and multiprotein pathways. CodeEvolver combines DNA shuffling and bioinformatics with systems biology to create new biocatalysts.


Company Growth (employees)
Type
Public
HQ
Redwood City, US
Founded
2002
Size (employees)
106 (est)+17%
Codexis was founded in 2002 and is headquartered in Redwood City, US

Key People at Codexis

John Nicols

John Nicols

President & CEO
James Lalonde

James Lalonde

Senior Vice President, Research & Development

Codexis Office Locations

Codexis has an office in Redwood City
Redwood City, US (HQ)
200 Penobscot Dr

Codexis Data and Metrics

Codexis Financial Metrics

Codexis's revenue was reported to be $8 m in Q1, 2017
USD

Revenue (Q1, 2017)

8 m

Gross profit (Q1, 2017)

5 m

Gross profit margin (Q1, 2017), %

62%

Net income (Q1, 2017)

(7.5 m)

EBIT (Q1, 2017)

(7.5 m)

Market capitalization (15-Aug-2017)

248 m

Cash (31-Mar-2017)

13.9 m
Codexis's current market capitalization is $248 m.
USDFY, 2013FY, 2014FY, 2015FY, 2016

Revenue

31.9 m35.3 m41.8 m48.8 m

Revenue growth, %

11%18%17%

Cost of goods sold

9.8 m

Gross profit

39.1 m

Gross profit Margin, %

80%

Operating expense total

73.1 m54.4 m49.6 m57.4 m

EBIT

(41.1 m)(19.1 m)(7.8 m)(8.6 m)

EBIT margin, %

(129%)(54%)(19%)(18%)

Interest income

60 k18 k19 k60 k

Pre tax profit

(41.4 m)(19.3 m)(7.9 m)(8.6 m)

Income tax expense

(87 k)(256 k)

Net Income

(41.3 m)(19.1 m)(7.6 m)(8.6 m)
USDQ2, 2014Q3, 2014Q1, 2015Q2, 2015Q3, 2015Q1, 2016Q2, 2016Q3, 2016Q1, 2017

Revenue

6.6 m7.5 m6.8 m6 m17.4 m8 m16 m14.9 m8 m

Cost of goods sold

3 m

Gross profit

5 m

Gross profit Margin, %

62%

R&D expense

7.7 m5 m5.3 m5.2 m5 m5.7 m5.1 m5.5 m5.8 m

General and administrative expense

5.6 m5.2 m5.6 m5.3 m5.4 m6.8 m6.4 m5.2 m6.6 m

Operating expense total

13.4 m10.2 m10.9 m10.5 m10.4 m12.5 m11.5 m10.7 m12.4 m

EBIT

(8.9 m)(4.3 m)(5.5 m)(5.7 m)5.7 m(7 m)2.2 m1.4 m(7.5 m)

EBIT margin, %

(136%)(57%)(81%)(95%)33%(87%)14%10%(94%)

Interest income

3 k3 k4 k4 k4 k15 k13 k12 k18 k

Pre tax profit

(8.9 m)(4.3 m)(5.6 m)(5.8 m)5.7 m(7 m)2.2 m1.4 m(7.4 m)

Income tax expense

253 k12 k274 k11 k24 k

Net Income

(8.5 m)(4.6 m)(5.6 m)(5.4 m)5.4 m(7 m)2.2 m1.4 m(7.5 m)
USDFY, 2013FY, 2014FY, 2015FY, 2016

Cash

22.1 m26.5 m23.3 m19.2 m

Inventories

1.5 m1.4 m992 k825 k

Current Assets

35.8 m33 m32.8 m27.2 m

PP&E

8.4 m4 m3.1 m2.2 m

Goodwill

3.2 m3.2 m3.2 m3.2 m

Total Assets

58.8 m48.1 m44.6 m35.6 m

Accounts Payable

4 m4.7 m3.4 m4.2 m

Current Liabilities

11.2 m13.7 m14.8 m12.4 m

Total Liabilities

16.5 m

Additional Paid-in Capital

298.4 m302.4 m306 m311.2 m

Retained Earnings

(256.9 m)(275.9 m)(283.5 m)(292.1 m)

Total Equity

22.9 m19.1 m

Financial Leverage

2 x1.9 x
USDQ2, 2014Q3, 2014Q1, 2015Q2, 2015Q3, 2015Q1, 2016Q2, 2016Q3, 2016Q1, 2017

Cash

20.1 m21.5 m22.2 m16.6 m17 m22.2 m22.4 m14.9 m13.9 m

Inventories

2 m1.9 m992 k968 k678 k1 m1.2 m1.1 m1.1 m

Current Assets

26.9 m28.2 m27.6 m21.4 m32.3 m28.8 m27.9 m30.1 m21.7 m

PP&E

4.9 m4.4 m3.5 m3.2 m2.8 m2.8 m2.4 m2.3 m2.8 m

Goodwill

3.2 m3.2 m3.2 m3.2 m3.2 m3.2 m3.2 m3.2 m3.2 m

Total Assets

45.2 m44.8 m41.4 m35.3 m44.3 m39.2 m36.9 m38.5 m30.6 m

Accounts Payable

3.3 m2.5 m2 m1.7 m1.2 m2.9 m2.7 m2.1 m3.5 m

Current Liabilities

10.8 m11 m11.9 m11.4 m12.8 m16.5 m12.4 m11.7 m13.5 m

Additional Paid-in Capital

300.7 m301.4 m303.2 m303.3 m304.6 m306.3 m308 m309.3 m311.3 m

Retained Earnings

(271.7 m)(276.3 m)(281.5 m)(286.9 m)(281.5 m)(290.5 m)(288.2 m)(286.8 m)(299.5 m)

Total Equity

17.1 m23.3 m16.1 m19.7 m22.8 m11.7 m

Financial Leverage

2.1 x1.9 x2.4 x1.9 x1.7 x2.6 x
USDFY, 2013FY, 2014FY, 2015FY, 2016

Net Income

(41.3 m)(19.1 m)(7.6 m)(8.6 m)

Accounts Receivable

1.6 m1.6 m(3.5 m)1.4 m

Inventories

(185 k)92 k403 k167 k

Accounts Payable

308 k713 k(1.3 m)942 k

Cash From Operating Activities

(23 m)321 k(433 k)(2.7 m)

Purchases of PP&E

(1.2 m)(302 k)(1.2 m)(888 k)

Cash From Investing Activities

13.3 m4.6 m(1.3 m)(842 k)

Cash From Financing Activities

(147 k)(611 k)(1.5 m)(490 k)

Income Taxes Paid

103 k15 k8 k5 k
USDQ2, 2014Q3, 2014Q1, 2015Q2, 2015Q3, 2015Q1, 2016Q2, 2016Q3, 2016Q1, 2017

Net Income

(8.5 m)(4.6 m)(5.6 m)(5.4 m)5.4 m(7 m)2.2 m1.4 m(7.5 m)

Inventories

2 m992 k968 k678 k1 m1.2 m1.1 m1.1 m

Accounts Payable

3.3 m2.5 m2 m1.7 m1.2 m2.9 m2.7 m2.1 m3.5 m
USDY, 2017

Revenue/Employee

80.9 k

Financial Leverage

2.6 x

Codexis Market Value History

Traffic Overview of Codexis

Codexis Online and Social Media Presence

Codexis Company Life and Culture

You may also be interested in